Back to search

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED

9 contracts won£11,678,553 total value

Every public sector contract BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED for you, and alerts you the moment a renewal goes live.

Where they win

The sectors, tender types and buyers where BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED wins most often.

See every live NHS tenders and find your next contract before they do.

See all UK contract awards.

Sectors

Healthcare & Medical9

Top Buyers

Belfast Health & Social Care Trust
2 contracts
£5,300,000
The Clatterbridge Cancer Centre NHS Foundation Trust
2 contracts
£420,750
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
1 contract
£106,148
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
1 contract
£959,680
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
1 contract
£4,712,785
Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts)
1 contract
Western Health and Social Care Trust
1 contract
£179,190

Awards(9)

Sort:

YERVOY (IPILIMUMAB) CONCENTRATE FOR SOLUTION FOR INFUSION vial, PACK OF 1

Belfast Health & Social Care Trust
Belfast
£2,000,000
Awarded 7 Jul 2026
Ends 30 Jun 2028

OPDIVO (NIVOLUMAB) 600MG/5ML SOLUTION FOR INJECTION VIAL, 5 mL

Belfast Health & Social Care Trust
Belfast
£3,300,000
Awarded 7 Jul 2026
Ends 30 Jun 2028

Provision of Breyanzi CAR POS T-Cells

The Clatterbridge Cancer Centre NHS Foundation Trust
Bebington, Wirral
£140,250
Awarded 27 Apr 2026
Ends 29 Apr 2026

Provision of Breyanzi CAR POS T Cells

The Clatterbridge Cancer Centre NHS Foundation Trust
Bebington, Wirral
£280,500
Awarded 6 Mar 2026
Ends 7 Mar 2026

NP39724b Pomalidomide and Thalidomide

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Edinburgh
£959,680
Awarded 19 Jan 2025

Bristol Myers Squibb - WT2024-28 - POMALIDOMIDE (1mg, 2 mg, 3mg, 4mg) Capsules

Western Health and Social Care Trust
Londonderry
£179,190
Awarded 23 Sept 2024

Clozapine Tablets and Blood Testing Service

Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts)
Cardiff
Not specified
Awarded 9 Dec 2022
Ends 30 Jun 2026

Atazanavir / Cobicistat (Evotaz®)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Edinburgh
£106,148
Awarded 5 Feb 2022

Apixaban (Eliquis®)

The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
UK
£4,712,785
Awarded 14 Dec 2020

Know when BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED's contracts come up for renewal

Business predicts when each of these contracts is due to be re-tendered, follows BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.

Why track BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED?

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.

How renewal tracking works

We aggregate BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.

What you can do here

  • Review the full history. Every contract BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED has won, with the buyer, value and dates for each.
  • Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
  • Track and get alerted. Follow BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED and be notified when their contracts come up again (Business).
  • Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.

Frequently asked questions

Where does this data come from?

Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.

Is the contract history free?

Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.

How do you predict renewals?

From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.